Skip to main content

Table 1 Baseline characteristics of evaluable participants

From: Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

Characteristic Verum Placebo
  N = 55 N = 57
Female n (%) 48 (87.3) 49 (86.0)
Age y (SD) 40.4 (13.39) 36.4 (11.14)
BMI (SD) 23.16 (3.57) 23.17 (3.55)
Migraine type   
  With aura n (%) 22 (40.0) 16 (28.1)
  Without aura n (%) 28 (50.9) 37 (64.9)
Previous migraine prevention   
  Participants with no previous preventions n (%) 40 (72.7) 36 (63.2)
  Participants with 1-3 previous preventions n (%) 12 (21.8) 20 (35.0)
  Participants with more than 3 previous preventions n (%) 3 (5.4) 1 (1.8)
Medical history, diseases n (%) 43 (42.1) 59 (57.8)
Concomitant medication n (%) 24 (36.3) 42 (63.6)
  1. n denotes numbers, events or medication, respectively.